Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06284135
Other study ID # 2017-PS-03
Secondary ID PV6099
Status Completed
Phase N/A
First received
Last updated
Start date June 19, 2017
Est. completion date May 31, 2021

Study information

Verified date February 2024
Source Martini-Klinik am UKE GmbH
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A two-armed prospective randomised, controlled, single-centre trial on 1080 patients with prostate cancer who underwent robot-assisted radical prostatectomy with bilateral pelvic lymph node dissection was carried out. Patients in the intervention arm received fixation of the peritoneal flap of the bladder to the plexus Santorini at the end of surgery (Michl-technique, MT); in the control group, surgery was performed without this modification. The primary endpoint was the rate of lymphoceles requiring intervention.


Recruitment information / eligibility

Status Completed
Enrollment 1080
Est. completion date May 31, 2021
Est. primary completion date October 16, 2019
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - Declaration of consent signed - Minimum age 18 years - localised prostate carcinoma - planned DVRP with bilateral lymphadenectomy Exclusion Criteria: - patient's lack of capacity to consent - ORP - no planned PLND - metastatic prostate cancer - ASA status >3

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Michl-stitch
In the intervention group, a ventral fixation was performed by suturing the ventral bladder peritoneum to the plexus Santorini and from there to the right and left lateral endopelvic fascia (MICHL-stitch).

Locations

Country Name City State
Germany Martini-Klinik am UKE GmbH Hamburg

Sponsors (1)

Lead Sponsor Collaborator
Martini-Klinik am UKE GmbH

Country where clinical trial is conducted

Germany, 

References & Publications (6)

Grande P, Di Pierro GB, Mordasini L, Ferrari M, Wurnschimmel C, Danuser H, Mattei A. Prospective Randomized Trial Comparing Titanium Clips to Bipolar Coagulation in Sealing Lymphatic Vessels During Pelvic Lymph Node Dissection at the Time of Robot-assisted Radical Prostatectomy. Eur Urol. 2017 Feb;71(2):155-158. doi: 10.1016/j.eururo.2016.08.006. Epub 2016 Aug 17. — View Citation

Keskin MS, Argun OB, Obek C, Tufek I, Tuna MB, Mourmouris P, Erdogan S, Kural AR. The incidence and sequela of lymphocele formation after robot-assisted extended pelvic lymph node dissection. BJU Int. 2016 Jul;118(1):127-31. doi: 10.1111/bju.13425. Epub 2016 Feb 17. — View Citation

Lebeis C, Canes D, Sorcini A, Moinzadeh A. Novel Technique Prevents Lymphoceles After Transperitoneal Robotic-assisted Pelvic Lymph Node Dissection: Peritoneal Flap Interposition. Urology. 2015 Jun;85(6):1505-9. doi: 10.1016/j.urology.2015.02.034. — View Citation

Ploussard G, Briganti A, de la Taille A, Haese A, Heidenreich A, Menon M, Sulser T, Tewari AK, Eastham JA. Pelvic lymph node dissection during robot-assisted radical prostatectomy: efficacy, limitations, and complications-a systematic review of the literature. Eur Urol. 2014 Jan;65(1):7-16. doi: 10.1016/j.eururo.2013.03.057. Epub 2013 Apr 6. — View Citation

Waldert M, Remzi M, Klatte T, Klingler HC. FloSeal reduces the incidence of lymphoceles after lymphadenectomies in laparoscopic and robot-assisted extraperitoneal radical prostatectomy. J Endourol. 2011 Jun;25(6):969-73. doi: 10.1089/end.2010.0635. Epub 2011 May 4. — View Citation

Yasumizu Y, Miyajima A, Maeda T, Takeda T, Hasegawa M, Kosaka T, Kikuchi E, Oya M. How can lymphocele development be prevented after laparoscopic radical prostatectomy? J Endourol. 2013 Apr;27(4):447-51. doi: 10.1089/end.2012.0356. Epub 2012 Dec 5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary rate of lymphoceles requiring intervention after RARP Clavien-Dindo >2° one year follow-up
Secondary total lymphocele rate after RARP Clavien-Dindo one year follow-up
Secondary other complications = grade IIIa according to Clavien-Dindo after RARP Clavien-Dindo one year follow-up
Secondary continence rates after RARP EPIC one year folow-up
See also
  Status Clinical Trial Phase
Completed NCT03567525 - Peritoneal Iliac Flap and Lymphocele Formation After Robotic Radical Prostatectomy N/A
Terminated NCT03006562 - PREvention of VENous ThromboEmbolism Following Radical Prostatectomy Phase 4
Completed NCT04205864 - Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer. N/A
Completed NCT04853095 - Effect of Peritoneal Fixation on Lymphocele Formation N/A